TRANSACTION RECORD

DOWNLOAD RECORD   vCard | CSV | PDF
Company Name Ribometrix
Status Private & Independent
Industry Biopharmaceutical
Company Description A platform therapeutics company discovering small molecule drugs that target functional RNA structures to create new avenues to treat human disease.
Mailing Address 6 Davis Dr. 
Durham, NC 27709
USA  Map
Phone Undisclosed
Website www.ribometrix.com
Email Click for Free Trial
Profile
Social Media
Company News
Facebook
YouTube
 
Company Management
Title Name Email Profile
     
Chief Executive Officer Solomon, Michael
Chief Scientific Officer Reardon, John
Founder Weeks, Kevin
Vice President Hertzog, Donald
VP - Bus. Development Williams, Martin
VP - Finance Kearns, Jonathan
VP - Human Resources Kilpatrick, Denise
VP - R & D Warner, Katherine
Information Release Date 11/14/2018
Transaction Type Venture Equity
Amount $30,000,000
Round Series A
Proceeds Purposes Funds will allow for advancement of lead molecules and expand its powerful platform for small molecule discovery based on 3D structural analysis of RNA.
Transaction Investors
M Capital
(Lead Investor)
Amgen Ventures
Pappas Ventures
Illumina Ventures
SV Health Investors
Michael Solomon
AbbVie Biotech Ventures
John Gustofson
Hatteras Venture Partners
Michael Dial
MP Healthcare Venture Management
Dementia Discovery Fund
Alexandria Venture Investments

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.


PCI - Level1